Afanat 30mg

100 INR/Bottle

Get a Price/Quote

Product Details:

Enzyme Types Other
Feature Other
Ingredients Other
Application Other
Physical Color/Texture Other
Fermentation Smell Normal Smell
Storage Instructions Store in a Dry Place
Supply Ability : 1000 Bottle Per Day
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Price And Quantity

Price 100 INR/Bottle
Minimum Order Quantity 1 Bottle Bottle

Product Specifications

Application Other
Fermentation Smell Normal Smell
Ingredients Other
Physical Color/Texture Other
Feature Other
Enzyme Types Other
Storage Instructions Store in a Dry Place
Shelf Life 2 Years Years

Trade Information

FOB Port Mumbai
Payment Terms Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Delivery Point (DP), Days after Acceptance (DA), Cheque, Cash in Advance (CID), Cash Advance (CA), Cash on Delivery (COD), Cash Against Delivery (CAD)
Supply Ability 1000 Bottle Per Day
Delivery Time 24-48 Hours
Sample Available Yes
Sample Policy Sample costs shipping and taxes has to be paid by the buyer
Packaging Details 1 x 20 Tablets in a Bottle
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market All India
Certifications ISO 9001;2015 Drug License Exports and Imports License Food license

Product Description

Afanat is used to treatment of non-small cell lung carcinoma (NSCLC). It becomes to the tyrosine kinase inhibitor family of the drug. It is taken by mouth. It is primarily used to treat cases of NSCLC that harbor variation inthe epidermal growth factor receptor (EGFR) chromosome. Afatinib is an effective and selective, irreversible ErbBfamily blocker. Afatinib covalently binds to and irreversibly blocks indicating from all homo and heterodimers formed by the ErbB family members EGFR (ErbB1), HER2 (ErbB2), ErbB3 and ErbB4. fatinib covalently binds to the kinase rule of EGFR (ErbB1), HER2 (ErbB2), andHER4 (ErbB4) and irreversibly inhibits tyrosine kinase autophosphorylation, resulting in the down-regulation of ErbB in.

Uses:

non-small cell lung carcinoma